Senseonics, Ascensia launch Eversense 365 year-long CGM in the U.S.
October 1, 2024
Ascensia Diabetes Care announced today that it launched the Eversense 365 CGM system from Senseonics (NYSE:SENS) in the U.S.
Ascensia Diabetes Care announced today that it launched the Eversense 365 CGM system from Senseonics (NYSE:SENS) in the U.S.
FLOWOOD, Miss., Sept. 10, 2024 /PRNewswire/ — Zavation Medical Products, LLC (“Zavation”), an innovator in spinal device technology, proudly announces the launch of its latest product—the Varisync® ALIF System. Engineered to streamline ALIF procedures, the Varisync system offers customization and efficiency with two spacer fixation options: anchors and screws.
Developed using Unity, the software allows viewing of advanced 3D reconstructions directly on a surgeon’s computer.
Monteris Medical today said its launch of the NeuroBlate NB3 FullFire makes it the smallest laser probe for brain procedures on the market.
The first U.S. commercial cases have been completed with the Abbott (NYSE: ABT)+
Aveir dual-chamber leadless pacemaker technology.